Teva, Eli Lilly Spar Over Possible New Drug Patent Trial
Eli Lilly and Teva on Friday sparred over whether a new trial should be held in Massachusetts federal court over the validity of patents related to Teva's migraine drug Ajovy after...To view the full article, register now.
Already a subscriber? Click here to view full article